Atopic dermatitis flare
Showing 26 - 50 of 2,712
Healthy, Atopic Dermatitis Trial in Daytona Beach (LY3872386, Prednisone, Placebo)
Not yet recruiting
- Healthy
- Atopic Dermatitis
- LY3872386
- +2 more
-
Daytona Beach, FloridaFortrea Clinical Research Unit
Nov 1, 2023
Atopic Dermatitis Trial in Montréal (Triamcinolone Acetonide (Aristocort® C), Vehicle)
Recruiting
- Atopic Dermatitis
- Triamcinolone Acetonide (Aristocort® C)
- Vehicle
-
Montréal, Quebec, CanadaInnovaderm Research Inc.
Apr 25, 2023
Complementary and Alternative Medicine in Children and Atopic
Not yet recruiting
- Atopic Dermatitis
- Self-administered questionnaire
-
Nancy, FranceUniversity Hospital of Nancy
Apr 18, 2023
Atopic Dermatitis Trial in Helsinki (Nature-based exposure by biodiversity component in lotion., Placebo group using colored
Active, not recruiting
- Atopic Dermatitis
- Nature-based exposure by biodiversity component in lotion.
- Placebo group using colored lotion.
-
Helsinki, FinlandUute Scientific Oy
Nov 8, 2023
Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema Trial in San Francisco (Dupilumab)
Recruiting
- Atopic Dermatitis
- +3 more
-
San Francisco, CaliforniaUCSF Psoriasis and Skin Treatment Center
Jan 25, 2023
Atopic Dermatitis, Eczema-Prone Skin Trial in Schenefeld (Body Lotion and Intensive Care)
Active, not recruiting
- Atopic Dermatitis
- Eczema-Prone Skin
- Body Lotion and Intensive Care
-
Schenefeld, GermanySGS proderm GmbH
Mar 28, 2023
Psoriasis, Atopic Dermatitis Trial in United States (XmAb27564, Placebo)
Recruiting
- Psoriasis
- Atopic Dermatitis
- XmAb27564
- Placebo
-
Thousand Oaks, California
- +3 more
Aug 22, 2023
Elidel® in South and East Asian Pediatric Atopic Dermatitis.
Not yet recruiting
- Mild to Moderate Atopic Dermatitis
- Elidel 1% Topical Cream
- (no location specified)
Sep 18, 2023
Hemay005, Atopic Dermatitis Trial in Shijiazhuang (Hemay005)
Recruiting
- Hemay005, Atopic Dermatitis
-
Shijiazhuang, Hebei, ChinaFirst Hospital of Hebei Medical University
Mar 14, 2023
Atopic Dermatitis in Premature Infants
Completed
- Atopic Dermatitis
- Lacticaseibacillus rhamnosus
- Lactobacillus acidophilus + Bifidobacterium bifidum
- (no location specified)
Sep 6, 2023
Cutaneous Nerves CNS Itch Trial in Minneapolis (Clonidine, Naltrexone)
Completed
- Cutaneous Nerves CNS Itch
-
Minneapolis, MinnesotaUniversity of Minnesota Department of Dermatology
Jan 23, 2023
Atopic Dermatitis Trial (LEO 138559, Placebo)
Not yet recruiting
- Atopic Dermatitis
- LEO 138559
- Placebo
- (no location specified)
Jun 20, 2023
Atopic Dermatitis Trial (Caffeine, Metoprolol, Midazolam)
Not yet recruiting
- Atopic Dermatitis
- Caffeine
- +6 more
- (no location specified)
May 26, 2023
Atopic Dermatitis, Atopic Dermatitis Eczema Trial in San Francisco (Dupilumab)
Completed
- Atopic Dermatitis
- Atopic Dermatitis Eczema
-
San Francisco, CaliforniaUCSF Psoriasis and Skin Treatment Center
Jan 5, 2023
Atopic Dermatitis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )
Completed
- Atopic Dermatitis
- LNK01001 Dose A
- +2 more
-
Beijing, ChinaJianzhong Zhang
Oct 10, 2023
Atopic Dermatitis Trial in Canada, United States (Oral EP262, Placebo)
Recruiting
- Atopic Dermatitis
- Oral EP262
- Placebo
-
Birmingham, Alabama
- +9 more
Nov 28, 2023
Atopic Dermatitis Trial (SAR444656 (KT-474), Placebo)
Not yet recruiting
- Atopic Dermatitis
- SAR444656 (KT-474)
- Placebo
- (no location specified)
Sep 21, 2023
Canadian Patients Receiving Dupixent® for Moderate to Severe
Recruiting
- Moderate to Severe Atopic Dermatitis
-
Toronto, Ontario, Canada
- +1 more
Oct 24, 2023
Atopic Dermatitis Trial in Italy (LimpiAD 2,5% plus cream, Vehicle, Emollient)
Recruiting
- Atopic Dermatitis
- LimpiAD 2,5% plus cream
- +2 more
-
Castellammare di Stabia, Napoli, Italy
- +4 more
Aug 2, 2023
Atopic Dermatitis Trial in Madrid (Cyclosporin A, Follow-up of Cyclospoin treatment already started)
Recruiting
- Atopic Dermatitis
- Cyclosporin A
- Follow-up of Cyclospoin treatment already started
-
Madrid, SpainHospital La Paz
Jan 11, 2023
Atopic Dermatitis Trial in Bexley (Part 1 ADX-629 (Open-label))
Not yet recruiting
- Atopic Dermatitis
- Part 1 ADX-629 (Open-label)
-
Bexley, OhioBexley Dermatology Research
Feb 6, 2023
Atopic Dermatitis Trial in Italy (LimpiAD cream 2,5% plus, Vehicle, Emollient)
Recruiting
- Atopic Dermatitis
- LimpiAD cream 2,5% plus
- +2 more
-
Bari, Italy
- +4 more
Jul 31, 2023
CLINICAL EFFICACY OF EMOLLIENTS IN ATOPIC DERMATITIS PATIENTS
Completed
- Atopic Dermatitis
- Cosmetic study
-
Rio de Janeiro, BrazilCIDP
Mar 13, 2023